RYALTRIS (OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE) Trademark

Trademark Overview


On Thursday, July 7, 2022, a trademark application was filed for RYALTRIS (OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE) with the United States Patent and Trademark Office. The USPTO has given the RYALTRIS (OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE) trademark a serial number of 97523305. The federal status of this trademark filing is REGISTERED as of Tuesday, February 13, 2024. This trademark is owned by Glenmark Specialty S.A.. The RYALTRIS (OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE) trademark is filed in the Pharmaceutical Products category with the following description:

Antihistamine, nasal steroid, nasal spray product for treatment of respiratory disorder; Antihistamine delivery device sold filled; nasal steroid delivery device sold filled
ryaltris (olopatadine hydrochloride and mometasone furoate)

General Information


Serial Number97523305
Word MarkRYALTRIS (OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE)
Filing DateThursday, July 7, 2022
Status700 - REGISTERED
Status DateTuesday, February 13, 2024
Registration Number7306494
Registration DateTuesday, February 13, 2024
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 22, 2023

Trademark Statements


Description of MarkThe mark consists of a three-dimensional trade dress packaging carton for the goods, in which the front and left side panels feature colored overlapping arches, colored purple (Pantone code PMS 682), light blue (Pantone code PMS 311) and light green (Pantone code PMS 374), the colors are fading toward the wide parts of the arches. The front panel and back panel feature the stylized word "RYALTRIS" in purple above the words "(OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE)" in black. This wording appears in the upper portion of the front and back panels, right to the light blue arch. The back panel of carton features the same colored arches, but they are wider at the place of overlap and only part of the light blue arch slightly overruns on the right panel on one side and parts of the light blue and light green arches from the front panel appear a little on the other side, at the bottom, whereas most of the right panel does not feature any elements of the trade dress. The backgrounds of the panels are white. The matter shown by the broken or dotted lines is not a part of the mark and serves only to show the position of the mark.
Goods and ServicesAntihistamine, nasal steroid, nasal spray product for treatment of respiratory disorder; Antihistamine delivery device sold filled; nasal steroid delivery device sold filled
Indication of Colors claimedThe color(s) purple, light blue, light green, black and white is/are claimed as a feature of the mark.
NOT AVAILABLE"OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 24, 2022
Primary Code005
First Use Anywhere DateThursday, August 18, 2022
First Use In Commerce DateThursday, August 18, 2022

Trademark Owner History


Party NameGlenmark Specialty S.A.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressLa Chaux-De-Fonds 2300
CH

Party NameGlenmark Specialty S.A.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressNeuchâtel 2000
CH

Party NameGlenmark Specialty S.A.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressNeuchâtel 2000
CH

Trademark Events


Event DateEvent Description
Monday, August 8, 2022TEAS REQUEST TO CHANGE FILING DATE.
Saturday, July 30, 2022NEW APPLICATION ENTERED
Monday, August 8, 2022TEAS PETITION TO DIRECTOR RECEIVED
Monday, August 8, 2022PETITION TO DIRECTOR RECEIVED
Monday, August 22, 2022ASSIGNED TO PETITION STAFF
Wednesday, August 24, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 24, 2022REQUEST TO CORRECT FILING DATE DENIED
Thursday, August 25, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, May 12, 2023ASSIGNED TO EXAMINER
Monday, June 12, 2023ASSIGNED TO PETITION STAFF
Tuesday, July 18, 2023PETITION TO DIRECTOR GRANTED
Thursday, July 20, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 2, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 22, 2023PUBLISHED FOR OPPOSITION
Tuesday, August 22, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 17, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 13, 2023USE AMENDMENT FILED
Wednesday, December 13, 2023TEAS STATEMENT OF USE RECEIVED
Thursday, January 4, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, January 5, 2024STATEMENT OF USE PROCESSING COMPLETE
Monday, January 8, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, January 9, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, February 13, 2024REGISTERED-PRINCIPAL REGISTER
Monday, May 19, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, May 19, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 19, 2025TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, May 19, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, May 19, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, May 19, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 13, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED